These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 35583359)

  • 21. Comparison of the Xpert Flu/RSV XC and Xpress Flu/RSV Assays.
    Popowitch EB; Miller MB
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29769281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-center evaluation of Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV molecular point-of-care test.
    Sluimer J; Goderski G; van den Brink S; Broeders M; Rahamat-Langendoen J; Then E; Wijsman L; Wolters F; van de Bovenkamp J; Melchers WJ; Meijer A
    J Clin Virol Plus; 2021 Dec; 1(4):100042. PubMed ID: 35262024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the molecular Xpert Xpress Flu/RSV assay vs. Alere i Influenza A & B assay for rapid detection of influenza viruses.
    Chen JH; Lam HY; Yip CC; Cheng VC; Chan JF; Leung TH; Sridhar S; Chan KH; Tang BS; Yuen KY
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):177-180. PubMed ID: 29262988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Alinity m Resp-4-Plex Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2, Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus.
    Zhen W; Manji R; Smith E; Wuitschick J; Lucic D; Berry GJ
    Microbiol Spectr; 2022 Feb; 10(1):e0109021. PubMed ID: 35107357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from Children.
    Banerjee D; Kanwar N; Hassan F; Essmyer C; Selvarangan R
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30185508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xpert Xpress Flu/RSV: Validation and impact evaluation at a large UK hospital trust.
    Morris TC; Bird PW; Horvath-Papp E; Dhillon JK; May S; Tang JW
    J Med Virol; 2021 Aug; 93(8):5146-5151. PubMed ID: 33559907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Evaluation of a Standard M10 Assay with Xpert Xpress for the Rapid Molecular Diagnosis of SARS-CoV-2, Influenza A/B Virus, and Respiratory Syncytial Virus.
    Abdullah A; Sam IC; Ong YJ; Theo CH; Pukhari MH; Chan YF
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A and influenza B in a prospective cohort from China.
    Zou X; Chang K; Wang Y; Li M; Zhang W; Wang C; Lu B; Xiong Z; Han J; Zhang Y; Zhao J; Cao B;
    Int J Infect Dis; 2019 Mar; 80():92-97. PubMed ID: 30634045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the Cepheid Xpert® Xpress SARS-CoV-2 using upper and lower respiratory tract specimens.
    Rong K; Cabrera A; Delport J; Schofield S; AlMutawa F
    Eur J Microbiol Immunol (Bp); 2022 Mar; 12(1):18-21. PubMed ID: 35286278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Kaira COVID-19/Flu/RSV Detection Kit for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus: A comparative study with the PowerChek SARS-CoV-2, influenza A&B, RSV Multiplex Real-time PCR Kit.
    Kim TY; Bae GE; Kim JY; Kang M; Jang JH; Huh HJ; Chung DR; Lee NY
    PLoS One; 2022; 17(12):e0278530. PubMed ID: 36516190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accurate detection of influenza A virus by use of a novel cross-priming isothermal amplification-based point-of-care assay.
    Deng J; Zhu H; An S; Huang H; Wang R; Chen Y; Chen P; Yu X
    Microbiol Spectr; 2024 Mar; 12(3):e0307423. PubMed ID: 38349165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of the cycle threshold value of the Xpert Xpress SARS-CoV-2/Flu/RSV test that corresponds to the presence of infectious SARS-CoV-2 in anterior nasal swabs.
    Relich RF; Van Benten K; Lei G-S; Robinson CM; Carozza M; Sahoo MK; Huang C; Solis D; Sibai M; Myers CA; Sikorski C; Balagot C; Yang D; Pinsky BA; Loeffelholz MJ
    Microbiol Spectr; 2024 Apr; 12(4):e0390823. PubMed ID: 38466093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of influenza virus infection.
    Schmidt RLJ; Simon A; Popow-Kraupp T; Laggner A; Haslacher H; Fritzer-Szekeres M; Redlberger-Fritz M; Mayer FJ
    Clin Microbiol Infect; 2019 Aug; 25(8):1032-1037. PubMed ID: 30583060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test for bronchoalveolar lavage.
    Phan T; Mays A; McCullough M; Wells A
    J Clin Virol Plus; 2022 Jun; 2(2):100067. PubMed ID: 35262037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of the Xpert Xpress CoV-2/Flu/RSV Plus Kit: A Glance at RSV Infection in Adults and Coinfection Rate.
    Alkharsah KR
    Saudi J Med Med Sci; 2024; 12(2):182-187. PubMed ID: 38764565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing the limits of multiplex respiratory virus assays for SARS-CoV-2 at high cycle threshold values: Comparative performance of cobas 6800/8800 SARS-CoV-2 & Influenza A/B, Xpert Xpress SARS-CoV-2/Flu/RSV, and cobas Liat SARS-CoV-2 & Influenza A/B.
    Matic N; Lawson T; Ritchie G; Lowe CF; Romney MG
    J Assoc Med Microbiol Infect Dis Can; 2024 Jan; 8(4):328-335. PubMed ID: 38250621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test.
    Johnson G; Zubrzycki A; Henry M; Ranadheera C; Corbett C; Meyers AFA; Sandstrom PA; Becker MG
    J Clin Virol Plus; 2021 Jun; 1(1):100014. PubMed ID: 35262002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative practicability and analytical performances of Credo VitaPCR™ Flu A&B and Cepheid Xpert® Xpress Flu/RSV platforms.
    Mboumba Bouassa RS; Tonen-Wolyec S; Rodary J; Bélec L
    Diagn Microbiol Infect Dis; 2021 Aug; 100(4):115381. PubMed ID: 33852989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.